Latest Market Expansion News

Cyclopharm has secured a significant multi-site agreement with the University of Pennsylvania Health System, marking a major step in its US expansion with installations across 11 clinical locations.

Synlait Milk Limited has reported a significant half-year loss driven by manufacturing setbacks and market pressures, alongside a strategic recovery roadmap focused on asset sales and operational overhaul.

Advanced Energy Minerals is ramping up production capacity at its Quebec plant, leveraging patented low-cost technology and renewable energy to meet booming global demand for high purity alumina.

Memphasys Limited confirms uninterrupted operations across the Middle East and North Africa, securing new orders and advancing regulatory approvals despite ongoing regional tensions.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

Peak Processing Limited anticipates a surge in beverage production to approximately 1.4 million units in Q4 FY26, driven by strong customer demand and operational improvements. The company also reports near-perfect delivery performance and multiple new product listings with the Ontario Cannabis Store.

Oneview Healthcare has successfully raised A$19 million through a two-tranche placement and launched a Security Purchase Plan to further strengthen its financial position and accelerate AI development.

Osteopore Limited has secured non-exclusive distribution rights for an injectable regenerative bone filler across Southeast Asia, marking a strategic expansion of its orthopaedic product portfolio and opening new revenue channels.

RLF AgTech has completed its restructuring phase and is now shifting gears towards aggressive commercial execution under new CEO Stuart Upton. The company outlined its growth strategy and financial results in a recent investor webinar, signalling a clear path to profitability.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.

Little Green Pharma Ltd (ASX: LGP) has proposed a full acquisition of Cannatrek Ltd via a scheme of arrangement, creating a vertically integrated medicinal cannabis group with pro forma FY26 revenues exceeding AUD 100 million. The scheme, supported by an independent expert, offers liquidity and strategic growth opportunities amid regulatory and market risks.